SOLIGENIX, INC. Basic Shares Outstanding (Weighted Average)
SOLIGENIX, INC. (SNGX) reported Basic Shares Outstanding (Weighted Average) of 15.95 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 15.95M shares, a 386.54% increase year-over-year.
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 10.16M shares, a 233.32% increase year-over-year.
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 10.08M shares, a 301.41% increase year-over-year.
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 4.33M shares, a 96.45% increase year-over-year.
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 5.19M shares, a 212.50% increase from fiscal 2024.
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.66M shares, a 242.36% increase from fiscal 2023.
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 485.00K shares, a 83.11% decline from fiscal 2022.
- SOLIGENIX, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 2.87M shares, a 7.32% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 15.95M shares 10-Q · filed 2026-08-07 | 13.15M shares 10-Q · filed 2026-08-07 | 12.07M shares derived: average of 3 quarters · filed 2026-08-07 | 10.13M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | 10.16M shares 10-Q · filed 2026-05-08 | 10.12M shares derived: average of 2 quarters · filed 2026-05-08 | 8.19M shares derived: average of 3 quarters · filed 2026-05-08 | 6.96M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | 10.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 7.21M shares derived: average of 2 quarters · filed 2026-03-31 | 5.90M shares derived: average of 3 quarters · filed 2026-08-07 | 5.19M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 4.33M shares 10-Q · filed 2025-11-07 | 3.80M shares derived: average of 2 quarters · filed 2026-08-07 | 3.56M shares 10-Q · filed 2025-11-07 | 3.29M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | 3.28M shares 10-Q · filed 2026-08-07 | 3.16M shares 10-Q · filed 2026-08-07 | 2.95M shares derived: average of 3 quarters · filed 2026-08-07 | 2.76M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | 3.05M shares 10-Q · filed 2026-05-08 | 2.78M shares derived: average of 2 quarters · filed 2026-05-08 | 2.59M shares derived: average of 3 quarters · filed 2026-05-08 | 2.26M shares derived: average of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | 2.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.36M shares derived: average of 2 quarters · filed 2026-03-31 | 1.99M shares derived: average of 3 quarters · filed 2026-03-31 | 1.66M shares 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | 2.20M shares 10-Q · filed 2025-11-07 | 1.73M shares derived: average of 2 quarters · filed 2025-11-07 | 1.38M shares 10-Q · filed 2025-11-07 | 1.19M shares derived: average of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | 1.26M shares 10-Q · filed 2025-08-14 | 958.34K shares 10-Q · filed 2025-08-14 | 855.78K shares derived: average of 3 quarters · filed 2025-08-14 | 804.05K shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 657.70K shares 10-Q · filed 2025-05-09 | 10.52M shares 10-Q · filed 2024-05-10 | 654.18K shares derived: average of 2 quarters · filed 2025-05-09 | 652.41K shares derived: average of 3 quarters · filed 2025-05-09 | 602.56K shares derived: average of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | 650.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 649.76K shares derived: average of 2 quarters · filed 2025-03-21 | 584.19K shares derived: average of 3 quarters · filed 2025-03-21 | 485.00K shares 10-K · filed 2025-03-21 | 7.76M shares 10-K · filed 2024-03-15 | |||
| 2023-09-30 | 648.86K shares 10-Q · filed 2024-11-08 | 10.38M shares 10-Q · filed 2023-11-13 | 550.95K shares derived: average of 2 quarters · filed 2024-11-08 | 429.77K shares 10-Q · filed 2024-11-08 | 6.87M shares 10-Q · filed 2023-11-13 | 1.73M shares derived: average of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | 453.04K shares 10-Q · filed 2024-08-09 | 7.25M shares 10-Q · filed 2023-08-21 | 318.41K shares 10-Q · filed 2024-08-09 | 5.09M shares 10-Q · filed 2023-08-21 | 2.08M shares derived: average of 3 quarters · filed 2024-08-09 | 2.28M shares derived: average of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | 2.91M shares 10-Q · filed 2024-05-10 | 2.90M shares derived: average of 2 quarters · filed 2024-05-10 | 2.89M shares derived: average of 3 quarters · filed 2024-05-10 | 2.88M shares derived: average of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | 2.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 2.88M shares derived: average of 2 quarters · filed 2024-03-15 | 2.87M shares derived: average of 3 quarters · filed 2024-03-15 | 2.87M shares 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | 2.87M shares 10-Q · filed 2023-11-13 | 43.08M shares 10-Q · filed 2022-11-10 | 2.87M shares derived: average of 2 quarters · filed 2023-11-13 | 2.87M shares 10-Q · filed 2023-11-13 | 43.01M shares 10-Q · filed 2022-11-10 | -24.58M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 2.87M shares 10-Q · filed 2023-08-21 | 43.01M shares 10-Q · filed 2022-08-12 | 2.86M shares 10-Q · filed 2023-08-21 | 42.97M shares 10-Q · filed 2022-08-12 | -33.73M shares derived: average of 3 quarters · filed 2023-08-21 | -15.13M shares derived: average of 4 quarters · filed 2023-08-21 | ||
| 2022-03-31 | 2.86M shares 10-Q · filed 2023-05-15 | 42.92M shares 10-Q · filed 2022-05-13 | -52.03M shares derived: average of 2 quarters · filed 2023-05-15 | -21.12M shares derived: average of 3 quarters · filed 2023-05-15 | -5.82M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -106.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -33.12M shares derived: average of 2 quarters · filed 2023-03-31 | -8.72M shares derived: average of 3 quarters · filed 2023-03-31 | 2.68M shares 10-K · filed 2023-03-31 | 40.13M shares 10-K · filed 2022-03-29 | |||
| 2021-09-30 | 40.70M shares 10-Q · filed 2022-11-10 | 40.39M shares derived: average of 2 quarters · filed 2022-11-10 | 39.21M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 40.07M shares 10-Q · filed 2022-08-12 | 38.46M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 36.82M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 27.49M shares 10-K · filed 2022-03-29 | |||||||
| 2018-09-30 | 17.50M shares 10-Q · filed 2018-11-09 | 13.12M shares derived: average of 2 quarters · filed 2018-11-09 | 11.66M shares 10-Q · filed 2018-11-09 | 10.68M shares derived: average of 4 quarters · filed 2018-11-09 | ||||
| 2018-06-30 | 8.74M shares 10-Q · filed 2018-08-08 | 8.74M shares 10-Q · filed 2018-08-08 | 8.41M shares derived: average of 3 quarters · filed 2018-08-08 | 7.75M shares derived: average of 4 quarters · filed 2018-11-09 | ||||
| 2018-03-31 | 8.73M shares 10-Q · filed 2018-05-11 | 8.24M shares derived: average of 2 quarters · filed 2018-05-11 | 7.41M shares derived: average of 3 quarters · filed 2018-11-09 | 6.96M shares derived: average of 4 quarters · filed 2018-11-09 | ||||
| 2017-12-31 | 7.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 6.75M shares derived: average of 2 quarters · filed 2018-11-09 | 6.37M shares derived: average of 3 quarters · filed 2018-11-09 | 6.14M shares 10-K · filed 2018-03-15 | ||||
| 2017-09-30 | 5.76M shares 10-Q · filed 2018-11-09 | 5.68M shares derived: average of 2 quarters · filed 2018-11-09 | 5.61M shares 10-Q · filed 2018-11-09 | 5.26M shares derived: average of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | 5.60M shares 10-Q · filed 2018-08-08 | 5.54M shares 10-Q · filed 2018-08-08 | 5.09M shares derived: average of 3 quarters · filed 2018-08-08 | 4.67M shares derived: average of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | 5.47M shares 10-Q · filed 2018-05-11 | 4.83M shares derived: average of 2 quarters · filed 2018-05-11 | 4.36M shares derived: average of 3 quarters · filed 2018-05-11 | 4.07M shares derived: average of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | 4.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 3.81M shares derived: average of 2 quarters · filed 2018-03-15 | 3.60M shares derived: average of 3 quarters · filed 2018-03-15 | 3.48M shares 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | 3.43M shares 10-Q · filed 2017-11-06 | 3.30M shares derived: average of 2 quarters · filed 2017-11-06 | 3.25M shares 10-Q · filed 2017-11-06 | 3.13M shares derived: average of 4 quarters · filed 2017-11-06 | ||||
| 2016-06-30 | 3.18M shares 10-Q · filed 2017-08-11 | 31.77M shares 10-Q · filed 2016-08-11 | 3.15M shares 10-Q · filed 2017-08-11 | 31.52M shares 10-Q · filed 2016-08-11 | 3.02M shares derived: average of 3 quarters · filed 2017-08-11 | 2.93M shares derived: average of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | 3.13M shares 10-Q · filed 2017-05-11 | 31.28M shares 10-Q · filed 2016-05-12 | 2.95M shares derived: average of 2 quarters · filed 2017-05-11 | 2.85M shares derived: average of 3 quarters · filed 2017-05-11 | 8.57M shares derived: average of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | 2.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | 2.71M shares derived: average of 2 quarters · filed 2017-03-27 | 10.38M shares derived: average of 3 quarters · filed 2017-03-27 | 2.61M shares 10-K · filed 2017-03-27 | 26.07M shares 10-K · filed 2016-03-24 | |||
| 2015-09-30 | 2.65M shares 10-Q · filed 2016-11-10 | 26.48M shares 10-Q · filed 2015-11-12 | 14.19M shares derived: average of 2 quarters · filed 2016-11-10 | 2.55M shares 10-Q · filed 2016-11-10 | 25.54M shares 10-Q · filed 2015-11-12 | 18.74M shares derived: average of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | 25.73M shares 10-Q · filed 2016-08-11 | 25.07M shares 10-Q · filed 2016-08-11 | 24.11M shares derived: average of 3 quarters · filed 2016-08-11 | 23.25M shares derived: average of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | 24.41M shares 10-Q · filed 2016-05-12 | 23.30M shares derived: average of 2 quarters · filed 2016-05-12 | 22.42M shares derived: average of 3 quarters · filed 2016-05-12 | |||||
| 2014-12-31 | 22.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | 21.43M shares derived: average of 2 quarters · filed 2016-03-24 | 20.64M shares 10-K · filed 2016-03-24 | |||||
| 2014-09-30 | 20.67M shares 10-Q · filed 2015-11-12 | 20.12M shares 10-Q · filed 2015-11-12 | ||||||
| 2013-12-31 | 15.46M shares 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |